Category

• Pipeline2
• Business1

Organizations

• Bausch + Lomb66
• Eyes On Eyecare47
• Alcon, Inc.44
• American Optometric Association35
• Harrow29
• Glaukos26
• Regeneron23
• Topcon Healthcare23
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• CEO1
• Business Management1
• Clinical Trials1
• Eye Drops1
• Glaucoma1
• Glaucoma Medications1
• Inherited Retinal Disease1
• Leadership1
• Partnership1
• Pediatrics1

• Organizations: PolyActiva✕

Clear all

Pipeline

PolyActiva and RareSight to advance long-acting therapies for pediatric IRDs

Collaboration leverages PolyActiva’s PREZIA drug delivery platform to develop NCE-enabling pharmacologic drugs for early-onset vision loss.

Business

Leadership watch: PolyActiva, B+L, and Wills Eye make strategic changes

Check out the latest leadership news from the eyecare space, including two new execs at PolyActiva and a retinal disorder treatment specialist taking the helm at Wills Eye.

Pipeline

PolyActiva reports positive phase 1b/2a data on biodegradable glaucoma implant

Novel ocular implant technology is designed for sustained and daily drug delivery with repeat dosing, replacing the need for daily eye drops.